R&D mRNA technologies: Looking beyond COVID vaccines Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications.
R&D Sponsored Rare Disease Diagnostics: Advancing Orphan Drug Development ... This white paper is free and can be downloaded and read at your convenience
R&D Harnessing genetics to propel cancer research and clinical s... When navigating the landscape of pharmaceutical development, clinical trials represent both a crucial checkpoint and a formidable barrier.
R&D Closed and Collaborative: Mergers, acquisitions, and partner... Welcome to a new pharmaphorum round-up.
R&D Changing Faces – Pharma and biotech May and June 2024 Welcome back to another edition of Changing Faces.
R&D South Africa's HIV Research: Unlocking the mysteries of elit... In the global fight against HIV, South Africa stands at a unique crossroads.
News Biogen, Ionis trumpet Alzheimer's data, but shares dip Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.